Timolol Maleate
Rank #375 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$25.8M
Total Cost
1,129,537
Total Claims
$25.8M
Total Cost
15,071
Prescribers
$23
Cost per Claim
320,372
Beneficiaries
2,303,750
30-Day Fills
$1,714
Avg Cost/Provider
75
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$25.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $25.8M total
Top Prescribers of Timolol Maleate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Holly Holm | Ophthalmology | Brighton, MI | 647 | $74K |
| 2 | Alexander Zabaneh | Ophthalmology | Chula Vista, CA | 588 | $68K |
| 3 | George Malouf | Ophthalmology | Camp Springs, MD | 161 | $39K |
| 4 | Andrew Cho | Ophthalmology | Los Angeles, CA | 2,327 | $38K |
| 5 | Curtis Graf | Ophthalmology | Mobile, AL | 1,137 | $36K |
| 6 | William Mosier | Ophthalmology | Fullerton, CA | 519 | $35K |
| 7 | August Pasquale | Ophthalmology | Arnold, MD | 218 | $33K |
| 8 | Jody Piltz-Seymour | Ophthalmology | Huntingdon Valley, PA | 314 | $33K |
| 9 | Kevin Denny | Ophthalmology | San Francisco, CA | 266 | $32K |
| 10 | Nathalie Rioux | Ophthalmology | Greenfield, MA | 359 | $31K |
| 11 | Donna Siracuse-Lee | Ophthalmology | Taunton, MA | 390 | $31K |
| 12 | Teresa Chen | Ophthalmology | Boston, MA | 390 | $30K |
| 13 | Mark Rolain | Ophthalmology | Sterling Heights, MI | 315 | $30K |
| 14 | Michele Jamison | Ophthalmology | Rochester, NY | 534 | $30K |
| 15 | Joshua Hardin | Ophthalmology | Richmond, VA | 761 | $30K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 372 | Rotigotine (Neupro) | $26.2M | 23,665 |
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
| 374 | Perampanel (Fycompa) | $25.9M | 20,876 |
| 375 | Timolol Maleate (Timolol Maleate) | $25.8M | 1,129,537 |
| 376 | Amitriptyline Hcl (Amitriptyline Hcl) | $25.8M | 1,295,043 |
| 377 | Tezepelumab-Ekko (Tezspire) | $25.6M | 5,900 |
| 378 | Ponatinib Hcl (Iclusig) | $25.6M | 1,209 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology